Literature DB >> 31601089

New insights into the immunomodulatory role of exosomes in cardiovascular disease.

Wenyan Jiang1, Mei Wang2.   

Abstract

Exosomes, nanosized lipid bilayer membranous vesicles, are secreted by a variety of cells and contain protein, lipids, mRNA, miRNA, and signaling molecules that participate in intercellular material transfer and information exchange through binding, fusion or endocytosis. Exosomes mediate the gene expression of target cells and regulate pathological and physiological processes, thereby playing a key role in the occurrence and development of various diseases. Accumulated studies has shown that exosomes hold therapeutic potential though their anti-apoptotic and anti-fibrotic roles. They also have been shown to promote angiogenesis, inhibit ventricular remodeling and improve cardiac function, as well as inhibiting local inflammation and regulating the immune response. As such, exosomes represent a new target for the treatment of cardiovascular diseases. This review summarizes the literature in this field to date, including the basic biological characteristics of exosomes, and new progress in the understanding of the mechanisms of their involvement in immune regulation in cardiovascular diseases. In this way, it servrs as a basis for future research and the development of therapeutic exosomes. ©2019 Jiang and Wang Published by IMR press. All rights reserved.

Entities:  

Keywords:  Exosomes; cardiovascular diseases; immunomodulation; inflammation

Year:  2019        PMID: 31601089     DOI: 10.31083/j.rcm.2019.03.528

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  9 in total

1.  Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis.

Authors:  Libo Yang; Ting Wang; Xiaoxia Zhang; Hua Zhang; Ning Yan; Guoshan Zhang; Ru Yan; Yiwei Li; Jingjing Yu; Jun He; Shaobin Jia; Hao Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-02-17       Impact factor: 2.298

Review 2.  Advances in Exosomes Derived from Different Cell Sources and Cardiovascular Diseases.

Authors:  Bo Liang; Xin He; Yu-Xiu Zhao; Xiao-Xiao Zhang; Ning Gu
Journal:  Biomed Res Int       Date:  2020-07-07       Impact factor: 3.411

3.  Characterization of Endothelial Cells Associated with Cerebral Arteriovenous Malformation.

Authors:  Yu-Chen Jia; Jia-Yue Fu; Ping Huang; Zhan-Pu Zhang; Bo Chao; Jie Bai
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-20       Impact factor: 2.570

Review 4.  Cross-Talk between Lipoproteins and Inflammation: The Role of Microvesicles.

Authors:  Gemma Chiva-Blanch; Lina Badimon
Journal:  J Clin Med       Date:  2019-11-22       Impact factor: 4.241

5.  cRGDyK-modified procaine liposome inhibits the proliferation and motility of glioma cells via the ERK/p38MAPK pathway.

Authors:  Dedong Li; Jie Gao; Chenyi Yang; Bo Li; Jian Sun; Mingdong Yu; Ying Wang; Haiyun Wang; Yuechun Lu
Journal:  Exp Ther Med       Date:  2021-06-09       Impact factor: 2.447

6.  The inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell.

Authors:  Hong-Yan Meng; Li-Qing Chen; Li-Hui Chen
Journal:  BMC Musculoskelet Disord       Date:  2020-03-06       Impact factor: 2.362

7.  A circulating exosomal microRNA panel as a novel biomarker for monitoring post-transplant renal graft function.

Authors:  Yimeng Chen; Xu Han; Yangyang Sun; Xiaozhou He; Dong Xue
Journal:  J Cell Mol Med       Date:  2020-09-11       Impact factor: 5.310

Review 8.  Therapeutic Applications of Extracellular Vesicles for Myocardial Repair.

Authors:  Chunping Liu; Nathan Bayado; Dongyue He; Jie Li; Huiqi Chen; Longmei Li; Jinhua Li; Xinyao Long; Tingting Du; Jing Tang; Yue Dang; Zhijin Fan; Lei Wang; Phillip C Yang
Journal:  Front Cardiovasc Med       Date:  2021-12-09

9.  Thromboangiitis obliterans plasma-derived exosomal miR-223-5p inhibits cell viability and promotes cell apoptosis of human vascular smooth muscle cells by targeting VCAM1.

Authors:  Ying Deng; Jindong Tong; Weijun Shi; Zhongyi Tian; Bo Yu; Jingdong Tang
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.